Codexis, Inc. is a Pasadena-based biotechnology company that specializes in developing innovative solutions for pharmaceutical manufacturing and RNA production. Their highly customized biocatalysts and engineered enzymes are designed to optimize API manufacturing processes, increase yield, and reduce waste, while also overcoming obstacles in the production of quality RNA at a commercial scale. With a focus on sustainability and improving health, Codexis aims to create a brighter future through their cutting-edge technologies and strategic collaborations.
At Codexis, their CodeEvolver Platform and ECO Synthesis Technology are at the forefront of their research and development efforts. These technologies enable the company to innovate sustainable processes and products, as well as discover and develop effective therapeutics. With a commitment to social, environmental, and financial benefits, Codexis works closely with business partners and loyal customers to turn their goals into reality. Through their advancements in mRNA therapeutics and enzyme-catalyzed oligonucleotide synthesis, Codexis is paving the way for a healthier future.
Generated from the website